Arthritis, Musculoskeletal and Skin Diseases Research in Maryland
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $72.4 million to recipients in Maryland in 102 grants from fiscal 2021 to 2025, 2.8% of the program's national total. The Johns Hopkins University received the most, $38.7 million.
- Awarded in Maryland$72.4 million
- Awards102
- Share of the program2.8%
- Rank among states14th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 55 | $16.1 million |
| FY 2022 | 50 | $14.5 million |
| FY 2023 | 50 | $14.5 million |
| FY 2024 | 50 | $15.5 million |
| FY 2025 | 36 | $11.8 million |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Colleges and universities | 48 | $38.7 million |
| University of Maryland, Baltimore | Colleges and universities | 32 | $30.9 million |
| University of Maryland, College Park | Colleges and universities | 3 | $641,625 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Nonprofits | 1 | $427,288 |
| Medstar Health Research Institute Inc. | Nonprofits | 1 | $388,960 |
| Mira Medical, LLC | Small businesses | 1 | $306,858 |
| Advanced Molecular Healix Inc. | Small businesses | 1 | $296,256 |
| Aavogen Inc | Small businesses | 1 | $274,152 |
| Othro Therapeutics Inc. | Small businesses | 1 | $256,486 |
| Society for Muscle Biology, Inc | Nonprofits | 3 | $56,750 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Maryland?
$72.4 million from fiscal 2021 to 2025, across 102 awards. Maryland ranks 14th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Maryland?
The largest recipient is The Johns Hopkins University, with $38.7 million in 48 awards. Next are University of Maryland, Baltimore and University of Maryland, College Park.
Can organizations in Maryland apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies